Indian Startup Dognosis Uses AI to Train Dogs for Cancer Detection with 90% Accuracy

AI Meets Canine Biology in Cancer Screening Innovation

Dognosis, a Bengaluru-based startup, is advancing AI-assisted cancer detection by combining artificial intelligence with dogs' extraordinary olfactory capabilities1

1

2

2

. At a research center outside India's tech capital, 15 trained dogs wear customized 3D-printed helmets and harnesses packed with sensors that monitor their brain activity, respiration, and body language as they analyze human breath samples3

3

. Co-founder Akash Kulgod, who studied cognitive science at the University of California, Berkeley, describes the equipment as a "doggy 'Iron Man' suit" that transforms physiological responses into actionable data4

4

. The company, backed by venture-capital firms including Accel India, aims to launch commercially next year, positioning itself as the third such company globally after firms from Germany and Israel2

2

.

Non-Invasive Cancer Screening Method Shows Promise

The cancer screening method developed by Dognosis relies on a straightforward process that requires no direct patient-dog interaction. Patients breathe into a cotton mask for approximately 10 minutes, after which the sample is sealed and transported to the laboratory for analysis1

1

. Dogs possess around 300 million scent receptors compared to about five million in humans, enabling them to detect cancer-related odors created when diseases alter the chemicals released by the body4

4

. The AI analyzes patterns in how dogs react to these samples, with each animal capable of performing thousands of sniffs per hour2

2

. Co-founder Itamar Bitan, who spent four years in an Israeli special-forces canine unit, explains that dogs are trained using positive reinforcement to detect specific odors for rewards, with reactions ranging from running to feeders to freezing or scratching samples3

3

.

Study Results and Expert Caution on Early Cancer Detection

A recent Dognosis study involving more than 1,500 participants across six hospitals in Karnataka state was published in the Journal of Clinical Oncology, reporting an accuracy rate exceeding 90% across seven major cancer types2

2

4

4

. However, this company-reported result does not establish the technology as a reliable cancer diagnostic test. Independent oncologists emphasize the need for larger validation studies before drawing definitive conclusions. Santhosh Kumar Devadas, head of oncology at Ramaiah Memorial Hospital, stated: "The study is promising, as an early signal. But they need to do the study with a much larger group before we make any definitive conclusions"1

1

. Neelesh Reddy, a senior consultant oncologist at Manipal Hospitals, added that "only time will tell how this technology will be useful to the actual patients"3

3

.

Addressing India's Cancer Crisis Through Proactive Medicine

The potential public health impact of dogs sniff cancer technology is substantial in India, where one in nine of the country's 1.4 billion people are likely to develop cancer4

4

. Many patients receive late-stage cancer diagnoses only after the disease has advanced, making early detection critical for improving survival rates2

2

. Dognosis envisions its approach as an affordable first layer of screening deployed at scale, identifying potential cases for further conventional medical testing1

1

. The company collaborates with government medical institutions as it pursues commercial approval, aiming to improve proactive and preventative medicine while advancing human-canine communication3

3

.

Canine Team Operations and Future Testing Plans

The Dognosis team consists primarily of beagles, along with some Malinois and Shepherd mixes, sourced through adoption or legal breeders2

2

. Each dog maintains a work-life balance with work time limited to 30-45 minutes daily, and all animals are listed individually on the company website as official "sniffers" with their photographs4

4

. At the facility called "Sniffspace," dogs test human samples on platforms equipped with automatic feeders dispensing treats3

3

. Dognosis plans to conduct further trials and test in real-world programs as it works toward establishing whether this AI-powered, non-invasive cancer screening approach can reliably detect cancer in clinical settings1

1

. Watch for expanded trials involving larger participant groups and independent validation studies that will determine if this technology can transition from promising research to practical clinical application.